Presentation and pathophysiology of neuro-COVID
Letter to the Editor commenting on Orsucci D, Caldarazzo Ienco E, Nocita G, Napolitano A, Vista M. Neurological features of COVID-19 and their treatment: a review. Drugs Context. 2020;9:2020-5-1. https://doi.org/10.7573/dic.2020-5-1
Main Authors: | Josef Finsterer, Fulvio Alexandre Scorza, Alexandra Scorza |
---|---|
Format: | Article |
Language: | English |
Published: |
BioExcel Publishing Ltd
2021-08-01
|
Series: | Drugs in Context |
Subjects: | |
Online Access: | https://www.drugsincontext.com/presentation-and-pathophysiology-of-neuro-covid |
Similar Items
-
Response to ‘Presentation and pathophysiology of neuro-COVID’
by: Daniele Orsucci, et al.
Published: (2021-08-01) -
Perspectives of Neuro-COVID: Myasthenia
by: Josef Finsterer, et al.
Published: (2021-02-01) -
Pathophysiology of SARS-CoV-2-associated ischemic stroke is variegated
by: Fulvio A. Scorza, et al.
Published: (2021-09-01) -
The neurological significance of COVID-19: Lesson learn from the pandemic
by: Ahmad Faried, et al.
Published: (2020-12-01) -
Neurological Compromise Associated With COVID-19 Is Broader Than Anticipated; Comment on "COVID-19 Pandemic and Neurological Disease: A Critical Review of the Existing Literature"
by: Josef Finsterer, et al.
Published: (2020-11-01)